P/B Ratio (Price-to-Book Ratio) in Pharmaceuticals & Healthcare
How to interpret and apply p/b ratio (price-to-book ratio) when analyzing pharmaceuticals & healthcare stocks in US (NYSE/Nasdaq) markets, with reference to international markets like India.
Quick Recap: What is P/B Ratio (Price-to-Book Ratio)?
P/B ratio compares a stock's market price to its book value per share. It shows whether you're paying more or less than the company's net asset value.
P/B Ratio = Market Price per Share ÷ Book Value per Share
How P/B Ratio (Price-to-Book Ratio) Works Differently in Pharmaceuticals & Healthcare
R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
Typical Ranges for Pharmaceuticals & Healthcare
Typical P/B Ratio3-7x
General benchmark: Banking: 1.5-3.0, Capital-intensive industries: 1.0-2.5
Sector data last reviewed: 2026-04
Example Pharmaceuticals & Healthcare Companies to Analyze
US Market (NYSE / Nasdaq)
Indian Market (NSE / BSE)
Filter pharmaceuticals & healthcare stocks by p/b ratio and other metrics:
Key Takeaways
- P/B Ratio (Price-to-Book Ratio) in pharmaceuticals & healthcare should be compared against sector peers in the same market (US S&P 500 / Russell or Indian NSE / BSE), not the broad market average.
- Sector characteristics: R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
- Cross-list peers across markets, large-cap US names often set the global benchmark, while Indian peers can trade at different multiples due to growth and liquidity differences.
- Always cross-check with other metrics. No single ratio tells the full story.